Preview

Russian Journal of Cardiology

Advanced search

VASOSPASM AS A CAUSE OF TYPE 2 MYOCARDIAL INFARCTION. TACTICS OUTSIDE THE GUIDELINES

https://doi.org/10.15829/1560-4071-2017-9-93-98

Abstract

The review is focused on the recent data on the causes of type 2 myocardial infarction and specifics of its diagnostics and management in patients with vasospastic angina. Significance of the problem is based upon the fact that strategies of this sort of patients management are lacking and usually do not fit guidelines. There is absence of agreed princips of long term management of such patients. The selection of strategy (medication therapy, revascularization of the spastic region, prevention of complications and another infarction) is disputable. The case provided, illustrating some of the listed issues from a real practice point of view.

About the Authors

М. А. Lysenko
City Clinical Hospital № 52 of the Department of Health; N. I. Pirogov Russian National Research Medical University (RNRMU)
Russian Federation

Competing Interests: нет


А.  Е. Vanyukov
City Clinical Hospital № 52 of the Department of Health
Russian Federation

Competing Interests: нет


N. G. Poteshkina
City Clinical Hospital № 52 of the Department of Health; N. I. Pirogov Russian National Research Medical University (RNRMU)
Russian Federation

Competing Interests: нет


А. Yu. Suvorov
City Clinical Hospital № 52 of the Department of Health; N. I. Pirogov Russian National Research Medical University (RNRMU)
Russian Federation

Competing Interests: нет


I. V. Samsonova
City Clinical Hospital № 52 of the Department of Health
Russian Federation

Competing Interests: нет


Е. А. Kovalevskaya 
City Clinical Hospital № 52 of the Department of Health; N. I. Pirogov Russian National Research Medical University (RNRMU)
Russian Federation

Competing Interests: нет


References

1. Thygesen K, Alpert JS, Jaffe AS, et al. Third universal definition of myocardial infarction. Eur Heart J .Oxford University Press; 2012 ;33(20):2551–67.

2. Jaffe AS. Vasospasm and Type 2 AMI? 2015; 128 (4):329-30.

3. Stein GY, Herscovici G, Korenfeld R, et al. Type-II myocardial infarction--patient characteristics, management and outcomes. PLoS One .Public Library of Science; 2014 ;9(1):e84285.

4. Mihatov N, Januzzi JL, Gaggin HK. Type 2 myocardial infarction due to supply–demand mismatch. Trends Cardiovasc Med. 2017; pii: S1050-1738(17)30042-7.

5. Roffi M, Patrono C, Collet J-P, et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J .2016;37(3):267–315.

6. López-Cuenca A, Gómez-Molina M, Flores-Blanco PJ, et al. Comparison between type-2 and type-1 myocardial infarction: clinical features, treatment strategies and outcomes. J Geriatr Cardiol .Institute of Geriatric Cardiology, Chinese PLA General Hospital; 2016 ;13(1):15–22.

7. Nagayoshi Y, Kawano H, Kojima S, et al. Guidelines for Diagnosis and Treatment of Patients With Vasospastic Angina (Coronary Spastic Angina) (JCS 2013). Circ J .The Japanese Circulation Society; 2014;78(11):2779–801.

8. Montalescot G, Sechtem U, Achenbach S, et al. 2013 ESC guidelines on the management of stable coronary artery diseaseThe Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J .2013;34(38): 2949-3003.

9. Matsue Y, Yoshida K, Hoshino M, et al. Clinical Features and Prognosis of Type 2 Myocardial Infarction in Vasospastic Angina. Am J Med. 2015 ;128(4):389–95.

10. Lee DH, Park TK, Seong CS, et al. Gender differences in long-term clinical outcomes and prognostic factors in patients with vasospastic angina. Int J Cardiol .2017; pii: S0167-5273(16)34651-4.

11. Fihn SD, Blankenship JC, Alexander KP, et al. 2014 ACC/AHA/AATS/PCNA/SCAI/STS Focused Update of the Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease. J Am Coll Cardiol .2014; 64(18):1929-49.

12. Inamura Y, Nishizaki M, Shimizu M, et al. Early repolarization and positive T-wave alternans as risk markers for life-threatening arrhythmias in patients with vasospastic angina. Int J Cardiol .2015 ;196:7–13.

13. Matsue Y, Suzuki M, Nishizaki M, et al. Clinical implications of an implantable cardioverter-defibrillator in patients with vasospastic angina and lethal ventricular arrhythmia. J Am Coll Cardiol .2012 ;60(10):908–13.

14. Steg PG, James SK, Atar D, et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC). Eur Heart J .2012 ;33(20):2569–619.

15. Roffi M, Patrono C, Collet J-P, et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J .2016 ;37(3):267–315.


Supplementary files

1. Неозаглавлен
Subject
Type Исследовательские инструменты
Download (1MB)    
Indexing metadata ▾
2. Направительное письмо
Subject
Type Other
View (1MB)    
Indexing metadata ▾
3. Титульный лист
Subject
Type Other
Download (15KB)    
Indexing metadata ▾

Review

For citations:


Lysenko М.А., Vanyukov А. ., Poteshkina N.G., Suvorov А.Yu., Samsonova I.V., Kovalevskaya  Е.А. VASOSPASM AS A CAUSE OF TYPE 2 MYOCARDIAL INFARCTION. TACTICS OUTSIDE THE GUIDELINES. Russian Journal of Cardiology. 2017;(9):93-98. (In Russ.) https://doi.org/10.15829/1560-4071-2017-9-93-98

Views: 1423


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1560-4071 (Print)
ISSN 2618-7620 (Online)